FDA Panel Calls For More Warnings On Metal Hip Implants
A U.S. Food and Drug Administration advisory panel recommended Thursday that the labeling for metal-on-metal hip implants, the target of multiple recalls and massive litigation, include warnings for tumor-like growths and...To view the full article, register now.
Already a subscriber? Click here to view full article